- Agomab Therapeutics AGMB-3.08% initiated its Phase 2b NOV-ERA trial for ontunisertib in fibrostenosing Crohn's disease, a ...

Before your client signs the next subscription, there's a higher-value conversation to have — and a higher-value service to ...

Once the current process is visible, you can identify the problems, design a better future state and determine which ...

By clicking submit, you agree to share your email address with TFN to receive marketing, updates, and other emails from the ...

Causa Prima has raised a $20M seed round led by Base10 Partners. Its AI agents settle invoice disputes and payment terms between two companies. Total ...

Yooz, an AI-powered finance platform leader, today announced it has been named a Leader in the IDC MarketScape: Worldwide AI-Enabled Accounts Payable Automation Software for Midmarket 2026 Vendor ...

Repay Holdings Corporation (NASDAQ: RPAY) (“REPAY”), a leading provider of bill payment solutions, today announced its partnership with Emburse, a global leader in travel and expense management, and ...

New payment capabilities, supported by Stripe, allow Freehand’s AI Teams to audit, resolve, approve, pay and reconcile invoices end-to-end Freehand Pay Freehand Pay inside Freehand's AI Workspace: ...

Backed by Base10, Causa Prima’s software lets buyers’ and suppliers’ AI agents negotiate payment terms.